ZVRA Zevra Therapeutics Forecast, Technical & Fundamental Analysis
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases... Show more
ZVRA is expected to report earnings to rise 12.71% to 15 cents per share on November 11
Q3'26
Est.
$0.16
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.53
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of 14 cents, beating the estimate of 10 cents. With 494.45K shares outstanding, the current market capitalization sits at 744.67M.
A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with EDIT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then EDIT could also see price increases.
ZVRA in +4.77% Uptrend, growing for three consecutive days on September 02, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ZVRA advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZVRA's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on ZVRA as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ZVRA just turned positive on August 06, 2026. Looking at past instances where ZVRA's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
ZVRA moved above its 50-day moving average on September 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.421) is normal, around the industry mean (20.583). P/E Ratio (13.484) is within average values for comparable stocks, (27.923). ZVRA's Projected Growth (PEG Ratio) (10.667) is very high in comparison to the industry average of (2.559). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.495) is also within normal values, averaging (443.835).
